863713-59-1Relevant articles and documents
Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat
Hoi,Visintin,Okuyama,Gardiner,Kaup,Bennett,Baker,Selwood,Hiley
, p. 751 - 764 (2008/03/13)
Background and purpose: A putative novel cannabinoid receptor mediates vasorelaxation to anandamide and abnormal-cannabidiol and is blocked by O-1918 and by high concentrations of rimonabant. This study investigates VSN16, a novel water-soluble agonist, a